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ABSTRACT 
For the previous ten years, we have been 
studying intracelular transport of melanosoma1 
proteins and their biological and biochemical 
functions in melanoma cels. Melanosoma1 pro- 
teins, tyrosinase, tyrosinase-related protein 1 
(TYRP1) and TYRP2/DOPAchrome tautom- 
erase (DCT), gp100/Pme117 are transported 
from the trans-Golgi network (TGN) to early- stage melanosomes via endosoma1 compart- 
ments. We suggest that Rab7 is involved in the 
vesicular transport of tyrosinase and TYRP1 
and in the melanogenesis through the regulation 
of gp100/Pme117 maturation. TYRP1 and TYRP 
2/DCT were shown to play an essential role in 
suppressing TYR-mediated cytotoxicity in 
melanocytic cels, possibly through interaction 
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with TYR in melanosomes.
We also studied apoptotic cel death of melanoma cells and death mediators. Among 
p53 family members, p51A (p63) induced apopto- sis in both wild-type and mutant p53-express- 
ing melanoma cels more significantly than p53 
and p73β. Interferon(IFN) exerts anti-tumor ac- tivities possibly by regulating IFN-stimulated 
genes. Caspase-2 activation was commonly asso- 
ciated with induction of apoptosis in IFN一β一sen- sitive melanoma cels. The diacylglycero1 kinase 
(DGK) α, expressed in several human melanoma cel lines but not in melanocytes, was a novel 
positive regulator of NF-・KB, which suppresses 
TNF一α一induced melanoma cell apoptosis. 
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INTRODUCTION
The majority of melanoma cases derive from melanocytes in the skin, but small num- 
bers also appear in the mucosal membranes, eye 
and the central nervous system. The number of 
patients suffering from melanoma gradually in- 
creased in Japan from 1987 through 2001, par- ticularly those afflicted with the subtype of su- 
perficial spreading melanoma(SSM)'). The 140- month survival rates for females and males 
with Japanese melanoma were 70.6% and 60 
%, respectively'). A survey was conducted in 2006 and2007, in which 1,053 cases of malignant 
melanoma from 160 institutions in Japan were 
examined (male/female ratio:520/532; average age:62.1 years). According to the survey, among 
Clark's subtypes, acral lentiginous melanoma 
(ALM) occurred most frequently (51.2%), fol- 
lowed by nodular melanoma(NM,21.2%), SSM 
(16.2%) and lentigo maligna melanoma (LMM, 
7.9%)2). In the past ten years, the employment of sentinel lymph node biopsy using RI and dye 
has spread among the major institutions in Ja- pan, resulting in a decrease in the number of 
patients with lymphedema accompanied with 
complete lymph node dissection. Although early 
lesions of primary melanoma, namely melanoma 
f'n sftu and malignant melanoma with tumor 
thickness less than 1.0 mm, are curable by excl- 
Figure l Vesicular transports of melanosoma1 proteins and formation of melanosomes.Melanosoma1 proteins, tyrosinase, TYRP-1 and Pme117/gp100, are transported to early endosomes.Pme117/gp100 is then processed to generate N-terminal Mαto form fibrilar amyloid sheets. Tyrosinase 
and TYRP-1 are transported to stage II melanosomes through BLOC-1/AP-3 and BLC1/AP-1, respec-tively5). Rab7 accelerates the maturation of and accumulation of Pme117/gp100 Mαfragments to form stage I melanosomes. In the transport of tyrosinase and TYRP-1, Rab7 has some roles to enhance their move from early endosomes to stage II melanosomes. In details see text. 
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sion, successful treatment of metastatic mela- 
noma has been elusive thus far.
To develop melanoma-specific targeting 
and therapy, it is essential to elucidate biological 
and biochemical characterization of melanocytes 
and melanoma cells including melanogenesis, 
melanosome-associated proteins, apoptotic cel 
death and signal transduction pathways acti- 
vated or suppressed. In this review, we summa- 
rize our previous papers regarding the melano- 
genic proteins and apoptotic cel death of mela- 
noma cells. Melanin is synthesized and seques- 
tered within the membranous compartment in 
the cytoplasm of melanocytes called melano- 
somes. Melanosome-resident proteins are ex- 
pressed only in melanocytes and most of them 
are integral membrane proteins, such as ty- 
rosinase, tyrosinase-related protein 1 (TYRP1), TYRP2or DOPAchrome tautomerase(TYRP2/ 
DCT) and gp100 or Pme117 (gp100/Pme117)3),4). Melanosomes are considered to be lysosome-re- 
lated organeles derived from early endosoma1 
membranes5). However, a molecular basis of ve- 
sicular transport of the melanosome proteins 
and melanosome formation has not yet been elu- cidated.
Since induction of apoptosis in melanoma 
cells will provide important clues for effective 
therapy against malignant melanoma, we stud- 
ied apoptotic cell death mediated by p53 family 
members, interferon一β(IFN一β) and tumor ne- 
crosis factor一α(TNF一α). Since melanogenesis and the apoptotic pathway may be shared 
among various types of melanomas despite the 
different gene mutations and activated path-
ways, this research may contribute to the clini- 
cal treatment and management of melanomas. 
1. Vesicular transport of melanogenic proteins and melanosome formation
(l) Tyrosinase and TYRPlMelanosome biogenesis consists of multi- 
step processes that involve the synthesis of 
melanosoma1 proteins folowed by their vesicu- 
lar transport and post-translational modifica- 
tions such as glycosylation, proteolysis and 011- 
13 
gomerization. Tyrosinase, a critical enzyme for 
melanogenesis, and TYRP1, functioning as5,6- 
dihydroxyindole-2-carboxylic acid oxidase in 
mice, are transported from the trans-Golgi net- 
work(TGN) to early-stage melanosomes via en- dosoma1 compartments3). It has been reported 
that gp100/Pme117, a melanosoma1 structural 
protein, is also transported from TGN to early- 
stage melanosomes6). They pass through differ- 
ent pathways consisting of different molecules; 
tyrosinase and TYRP1 are transported from 
early BLOC-1-positive endosoma1 structures 
with AP-for AP-3 to stage II melanosomes, 
while gp100/Pme117 are moved to stage I mela- 
nosomes via early endosomes5),7)(Fig.1). W e showed the experimental findings suggesting 
Rab7,low-molecular-weight GTP-binding pro- 
tein, is involved in the vesicular transport of ty- rosinase and TYRP1, and in the maturation of 
gp100/Pme117.Rab7 is a member of the Rab small GTP-
binding protein and essential for the regulation 
of endosoma1/1ysosoma1 vesicular transport and 
phagocytosis8). Previously we have reported that Rab7 is localized on the melanosoma1 mem- 
brane of BI6 murine melanoma cells9). The cels 
treated with Rab7 antisense oligonucleotide re- 
vealed TYRP1 was confined to the perinuclear 
area, suggesting that Rab7 is involved in the 
transport of TYRP1 from TGN to melanosomes, 
possibly passing through late endosomes. Ex- 
ogenous expression of TYRP1 and Rab7N125I, a 
dominant negative mutant of Rab7, in the amelanotic melanoma cels revealed TYRP1 to 
be localized to early endosomes, suggesting that 
the transport of TYRP1 may require functional 
Rab7'°)(Fig.1).Immortal mouse melanocytes were trans- 
fected with plasmids carrying cDNA of wild- 
type and mutant Rab7s to analyze their differ- 
ential effects on the intracellular trafficking of 
tyrosinase, TYRP1 and gp100/Pme117. As a re- 
sult, the inhibition of the Rab7 function resulted 
in preferential TYRP1 elimination possibly by 
cellular degradation machinery. It has been sug- 
gested that the vesicular transport pathway of 
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TYRP1 from TGN to melanosomes is different 
from that of tyrosinase and gp100, and that Rab 
7 is a crucial regulator for TYRP1 transport in melanogenesis cascade'). 
(2) gpl00/Pmell7gp100/Pme117 is cleaved to its functional 
Mαand Mβfragments after being transported from the TGN to the stage I melanosomes. The 
N-terminal Mαfragments serve to form the 
fibrillar matrix of the organele'2),'3) In the subse- 
quent stages of maturation and eumelanogene- 
sis, the fibrilar amyloid sheets of Mαfragments 
alow the organelle to develop an ellipsoidal 
shape characteristic of the stage II melano- 
somes'3)(Fig.1). Melanins are deposited on these fibrillae, resulting in a progressively pigmented 
internal matrix (stage III). Melanin synthesis and deposition continue until little or no internal 
structure remains visible (stage IV). However, the precise mechanism of melanosome biogene- sis is stil unclear. W e studied the molecular 
mechanism of melanosome biogenesis in more 
detail, by investigating the functional relation- 
ship between Rab7 and gp100/Pme117.
In pigmented melanoma cels, wild-type 
Rab7 and its dominant active mutant(Rab7-Q67 
L), but not its dominant negative mutant(Rab7- T22N), were co-localized in the perinuclear re- 
gion with granules containing the stage I mela- 
nosomes where the ful-length, immature gp100 
/Pme117 was present.0ver-expression of Rab7- 
Q67L and, to a lesser extent, Rab7-WT in- creased the amount of proteolytica11y processed 
mature gp100. Moreover, siRNA-mediated Rab7 
-knockdown considerably inhibited the gp100/ Pme117 maturation. These results colectively 
suggest that the GTP-bound form of Rab7 pro- 
motes melanogenesis through the regulation of 
gp100/Pme117 maturation in melanoma cells'4) 
(Fig.1). Two possible mechanisms to promote the gp100/Pme117-processing can be hypothe- 
sized:1) Rab7 enhances the transport of gp100/ 
Pme117 to the stage I melanosomes, and2) Rab7 
promotes the transport of enzymes and their 
regulators that participate in the processing of 
gp100/Pme117. As for the first possibility, gp100 
/Pme117 was reported to have been moved 
from the TGN to the stage I melanosomes di- 
rectly and/or indirectly via the plasma mem- 
brane and early/late endosomes7),'5). 
(3) Biologic activities of tyrosinase, TYRPl and TYRP2/DCT
It is well known that the synthesis of mela- 
nin intermediates through tyrosinase involves 
the production of cytotoxic free radicals'6),'7). As 
previously reported'8), when cells are infected 
with recombinant adenovirus carrying ty- 
rosinase cDNA (Ad-TYR), they deteriorate to the point of death several days after virus in- oculation. However, when TYRP1or TYRP2/ 
DCT was co-expressed with tyrosinase in 
melanocytes and melanoma cels, but not in non 
-melanocytic cells, tyrosinase-mediated cell 
death was clearly suppressed. Western blot 
analysis revealed that expression of TYRP1 
hardly affected the amount of co-introduced ty- 
rosinase in either the melanocytic or non- 
melanocytic cells. In cells expressing both ty- 
rosinase and TYRP1or tyrosinase and TYRP2/ 
DCT, the amount of total melanin and/or 
eumelanin increased substantialy more than in 
cells expressing tyrosinase a1one.0n the other 
hand, levels of pheomelanin were similar in 
these three cell types. These findings suggest 
that TYRP1 and TYRP2/DCT play an essential 
role in suppressing tyrosinase-mediated cyto-
toxicity in melanocytic cells, possibly through in- 
teraction with tyrosinase in melanosomes, de- 
spite the increase of melanin'9).To further define the functional domain of
TYRP1 for tyrosinase-mediated melanin pro- 
duction and cytotoxicity, we constructed recom- 
binant adenoviruses that expressed missense or deletion mutants of human TYRP1. The mis- 
sense mutants HI92L and H377L, which af- 
fected N-terminal and C-terminal copper-bind- 
ing domains respectively,lost the additive activ- 
ity of TYRP1 to the tyrosinase-mediated mela- 
nin production. However,one (HI92L) showed suppression against tyrosinase-mediated cyto- 
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toxicity as effectively as wild-type TYRP1. On the other hand, three missense mutants whose 
defects were located between the38'h and517'h 
codons (S38C, C110Y, S354C and D517Y) re- tained the melanogenic activity, while losing the 
anti-cytotoxic activity. These results suggest that 1) the functional domains of TYRP1 for the 
melanogenic activity and the inhibition of ty- 
rosinase-mediated cytotoxicity are different and 
distinct, and 2) the anti-cytotoxic activity of TYRP1 may not be associated with the specific 
domain, but with the whole protein structure20). 
2. Induction and suppression of apoptotic cell death of melanoma cells
(l) p53 family membersMelanoma cells rarely contain mutant p53
and hardly undergo apoptosis by wild-type p53. 
By using recombinant adenoviruses that ex- 
press p53 or p53-related p51A (p63)or p73132'), we tested their apoptotic activities in melanoma 
cells. Yeast functional assay revealed a mutation 
of p53 at the258th codon (AAA [K] instead of 
GAA [E]) in one cell line,70W,out of six human melanoma cel lines analyzed. Adenovirus-medi- 
ated transfer of p53, p63, and/or p73βsup- pressed growth and induced apoptotic DNA 
fragmentation of SK-me1-23, SK-me1-118 and 
70W cels. Interestingly, p63 induced DNA frag- 
mentation in the cels more significantly than 
p53 and p73β. Apoptotic Bax and antiapoptotic Bc1-2 were not significantly up-or down-regu- 
lated by expression of p53, p63,or p73β, except for p53-expressing70W cels, which contained a 
larger amount of Bax protein than LacZ-ex- 
pressing cels. Activation of caspase-3 was dem- 
onstrated only in p63-expressing SK-me1-118 
cels. Thus, p63 can mediate apoptosis in both 
wild-type and mutant p53-expressing mela- 
noma cells more significantly than p53 and p73β. It also suggests that in melanoma cels, cellular 
target protein(s)other than Bc1-2 and Bax may be responsible for induction of p63-mediated 
apoptosis, and caspase-3 is not always involved 
in the apoptosis by p53 family members22). W e, 
15 
then, constructed eight different kinds of chi- 
meric p53 and p63 cDNAs to determine which 
subregion of p63 is essential for p63-mediated 
apoptosis. Finally, to identify celular genes that 
work transcriptiona1ly downstream of p63, we 
compared RNAs between Ad-LacZ- and Ad- 
p63-infected SK-MEL-118 cels by differential 
display and DNA microarray analyses. As a re- 
sult, more than20 species of celular genes were 
found to be up-regulated more than ten fold in 
the Ad-p63-infected SK-MEL-118 cells23). 
(2) IFNβAlthough the mechanisms of IFN-mediated 
cel death have not been fully elucidated, IFN is 
known as an effective anti-tumor agent. It in- 
duces many biological responses by regulating 
IFN-stimulated genes (ISGs)24). Several ISGs, such as double-stranded RNA-activated protein 
kinase, myxovirus resistance protein A, mela- 
noma differentiation associated gene-5 and tu- 
mor necrosis factor-related apoptosis-inducing 
ligand(TRAIL) are related to the anti-tumor ef- 
fects of IFN 25). It has been reported that IFN一βinduces apoptosis in melanoma cells more sig_ 
nificantly than IFN一αand IFN一γdo26). TRAIL, known as Ape2 ligand, is also a member of the 
TNF family of transmembrane proteins, and it 
leads tumor cels to apoptosis by stimulating 
death receptors27). It has been suggested that the involvement of TRAIL is essential for the 
apoptotic cascade induced by IFNs in certain melanoma cell lines, as well as other tumor cel 
lines26). To characterize the signaling pathway 
involved in IFN一β一mediated apoptosis, we ana- 
lyzed the biological effect of IFN一βon the cell death and caspase activation of melanoma cells. 
Among four human melanoma cell lines tested, 
MM418, SK-me1-23 and SK-me1-118 showed in- 
hibition of cel viability, increased apoptotic 
populations and up-regulation of caspase-3 ac- 
tivity by IFN一β. Furthermore, caspase-2 activ- ity was upregulated in all the IFN-l3-sensitive 
cel lines, although MM418, which is IFN一βsen_ sitive, did not show induction of TRAIL mRNA 
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by IFN-l3. On the other hand, G361 was not af- 
fected by IFN一β. However, treatment of G361 
cels with IFN一βsignificantly increased their sensitivity against exogenous TRAIL-mediated 
apoptosis accompanied with activation of cas- 
pase-2.Caspase-2 activation is commonly asso- 
ciated with induction of apoptosis in IFN一β一sen- sitive melanoma cells28). 
(3) NF-d  and TNF一αThe constitutive activation of nuclear factor 
--KB (NF-KB) is known to be an emerging hall- mark of melanoma and plays a pivotal role in 
many aspects of melanoma tumorigenesis, in- 
cluding protection from apoptosis29),30). A major apoptosis signaling pathway in melanoma cels 
relies on tumor necrosis factor(TNF)一αand the 
network associated with TNF receptor(TNFR)- 
1 signaling29),3°). Unlike Fas, which mainly func- tions as a stimulator of the apoptosis cascade, 
signaling from TNFR-1often results in inhibi- 
tion of apoptosis through the efficient activation of NF-KB. Therefore, the balance between the 
pro- and anti-apoptotic signals within the TNFR-1 framework is central in dictating 
whether TNFR-1 activation results in the TNF 
αー一dependent cell death in melanoma cells.
We investigated the implication of diacy1-
glycerol kinase(DGK) α(type I isoform) in mela- noma cels because we found that this DGK iso- 
form was expressed in several human mela- 
noma cell lines but not in melanocytes. Intrigu- 
ingly, the overexpression of wild-type DGKα, 
but not its kinase-dead mutant, markedly sup- 
pressed TNF一α一induced apoptosis of AKI hu- man melanoma cells. In the reverse experiment, 
siRNA-mediated knockdown of DGKαsignifi- 
cantly enhanced the apoptosis. The overexpres- 
sion of other type I isoforms(DGKBE-TAβand 
DGK、f) had,on the other hand, no detectable ef- fects on the apoptosis. These results indicate 
that DGKαspecifically suppresses the TNF一α一 
induced apoptosis through its catalytic action. 
W e found that the overexpression of DGKα一 
W T, but not DGKα一KD, further enhanced the 
TNF一α一stimulated transcriptional activity of an 
anti-apoptotic factor, NF-KB. Conversely, DGKαknockdown considerably inhibited the NF-KB 
activity. Moreover, an NF--KB inhibitor blunted 
the anti-apoptotic effect of DGKαoverexpres- 
sion. Together, these results strongly suggest 
that DGKαis a novel positive regulator of NF- 
KB, which suppresses TNF一α一induced mela- 
noma cell apoptosis3'). 
Discussions and perspectives 
gp100/Pme117 serves as the structural 
foundation of the fibrils in the stage I and I 
melanosomes and melanogenic enzymes, such as 
tyrosinase, TYRP1 and TYRP2/DCT. There- 
fore, they should be transported and enriched in 
the stage II melanosomes5). Patients with Her- 
mansky-Pudlack syndrome type2 (HPS-2) are 
reported to carry mutations in theβ3A subunit of AP-332). Since AP-3 coats are detected pri- 
marily on early endosoma1 tubules, and mis1oca1- 
ized tyrosinase in AP-3-deficient cels accumu- 
lates in the early endosomes and multivesicular 
bodies33),34), tyrosinase is transported to melano- somes via endosomes not directly to melano- 
somes from the TGN. It is not known what dif- 
ferentiates between melanosomes and ly- 
sosomes in melanocytic cels. It has been re- 
ported that gp100/Pme117 accumulates in the 
lysosomes of non-melanocytic cells35).Although direct physical interactions be-tween Rab7 and melanosoma1 proteins have not 
yet been shown, three studies suggest links be- 
tween them, including the vesicular trafficking 
of tyrosinase and TYRP1 to melanosomes by 
Rab7'o),'), and the effect of rab7on the matura- 
tion of gp100/Pme117'4). Since Rab7 controls mi- crotubule-mediated transport of the early mela- 
nosomes36), and the maturation of the early and 
late endosomes37), it is possible that Rab7 con- 
tributes to the effective trafficking of melanoso- 
mal proteins and the maturation of gp100/Pmel 
17. It is also possible that several factors, which 
participate in and/or enhance the proteolysis of 
gp100/Pmel17, are transported by Rab7 to the 
early melanosomes.
The p53 family members, tumor suppressor 
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genes, were shown to induce apoptosis in mela- 
noma cells. W e have constructed chimeric p53/ 
p63 cDNAs to test if the apoptosis can be in- 
duced in melanoma cels more significantly than 
p63.One of the chimeric p63/53 showed the 
strongest apoptotic activity in melanoma cels, 
and it may be possible to identify apoptosis-re- 
1ated genes through microarrays from mRNA in 
melanoma cells expressing this chimeric mole- 
cule. Research concerning this is ongoing.
Stage IV melanoma with dissemination to 
distant organs is invariably incurable. It is not 
possible to identify the patients who will re- 
spond to the systemic chemotherapy or IFN一βbefore treatment. In some melanoma cell lines, 
IFN一βcan induce apoptosis in the presence of 5 -azacytidine, suggesting that apoptotic genes 
are transcriptiona1y suppressed by methylation 
of genomic DNA 38),39). W e have been trying to identify the cellular genes that are epigeneti- 
cally suppressed in melanoma cels, and a novel 
micro RNA has been characterized(Nishizaka T et al, manuscript in preparation). This line of 
study may contribute to the elucidation of the 
mechanism of resistance of melanoma against 
IFN and chemotherapy and to epigenetic ther- 
apy. 
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